Clicky

Capricor Therapeutics, Inc.(CAPR)

Description: Capricor Therapeutics, Inc., a biotechnology company, is focused on the development of novel therapeutics to prevent and treat cardiovascular diseases. Its lead product candidates include CAP-1002 and Cenderitide. The company was founded in 2005 and is based in Beverly Hills, California.


Keywords: Biotechnology Life Sciences Cardiovascular Disease Vascular Disease Regulus Therapeutics

Home Page: www.capricor.com

CAPR Technical Analysis

10865 Road to the Cure
San Diego, CA 92121
United States
Phone: 310 358 3200


Officers

Name Title
Dr. Frank Isaac Litvack FACC, M.D. Exec. Chairman
Dr. Linda Marbán Ph.D. Co-Founder, Pres, CEO & Director
Mr. Anthony J. Bergmann M.B.A. CFO & Corp. Treasurer
Ms. Karen G. Krasney Exec. VP, Gen. Counsel & Sec.
Dr. Eduardo Marbán Co-Founder & Chairman of Scientific Advisory Board
Mr. Xavier Avat Chief Bus. Officer
Dr. Deborah D. Ascheim Consultant
Catherine Lee Kelleher Consultant

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 6.4959
Price-to-Sales TTM: 61.6934
IPO Date: 2007-02-13
Fiscal Year End: December
Full Time Employees: 48
Back to stocks